Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.

Zonozi, Reza; Laliberte, Karen; Huizenga, Noah R; Rosenthal, Jillian K; Jeyabalan, Anushya; Collins, A Bernard; Cortazar, Frank B; Niles, John L

Zonozi, Reza; Laliberte, Karen; Huizenga, Noah R; Rosenthal, Jillian K; Jeyabalan, Anushya; Collins, A Bernard; Cortazar, Frank B; Niles, John L.

Afiliación

Zonozi R; Vasculitis and Glomerulonephritis Center, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Harvard University, Boston, Massachusetts. Electronic address: rzonozi@yahoo.com.
Laliberte K; Vasculitis and Glomerulonephritis Center, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.
Huizenga NR; Vasculitis and Glomerulonephritis Center, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.
Rosenthal JK; Vasculitis and Glomerulonephritis Center, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.
Jeyabalan A; Vasculitis and Glomerulonephritis Center, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.
Collins AB; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Harvard University, Boston, Massachusetts.
Cortazar FB; New York Nephrology Vasculitis and Glomerular Center, Albany, New York.
Niles JL; Vasculitis and Glomerulonephritis Center, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Harvard University, Boston, Massachusetts.

Am J Kidney Dis ; 78(6): 793-803, 2021 12.

Article en En | MEDLINE | ID: mdl-34174365

Asunto(s)

Glomerulonefritis Membranosa; Ciclofosfamida/efectos adversos; Estudios de Seguimiento; Glomerulonefritis Membranosa/tratamiento farmacológico; Humanos; Inmunosupresores; Prednisona; Receptores de Fosfolipasa A2; Estudios Retrospectivos; Rituximab; Resultado del Tratamiento

Palabras clave

B-cell depletion; case series; cyclophosphamide; glucocorticoid; immunosuppressive regimen; membranous nephropathy (MN); nephrotic syndrome (NS); phospholipase A2 receptor (PLA2R); prednisone; proteinuria; relapse; remission; rituximab; serious adverse events (SAEs)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Glomerulonefritis Membranosa Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Am J Kidney Dis Año: 2021 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google